ILY-103

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameILY-103
Drug Alias NameClostridium difficile toxin-binding polymer (Amgen/Cubist)Clostridium difficile toxin-binding polymer (Ilypsa/Cubist)ILY-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial pathogenicity factor modulatorsLipopolysaccharide binding agent
TargetsUpdating
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesI.L.Y. Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesI.L.Y. SaCubist Pharmaceuticals IncAmgen Inc
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A